FEBUXOSTAT was studied in healthy patients in doses up to 300 mg daily for seven days without evidence of dose-limiting toxicities. No overdose of FEBUXOSTAT was reported in clinical studies. Patients should be managed by symptomatic and supportive care should there be an overdose.